Last reviewed · How we verify
NCT06913855
The Effects of EMLA Cream and Cold Application on Pain, Fear and Vital Signs Before Chest Tube Removal in Children
NA trial testing EMLA Cream in Chest Tube Removal in 66 participants. Completed in 5 July 2025.
5 July 2025
Quick facts
| Lead sponsor | Istanbul Medeniyet University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 66 |
| Start date | 5 April 2025 |
| Primary completion | 5 July 2025 |
| Estimated completion | 5 July 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- EMLA Cream
- Cold application
Conditions studied
- Chest Tube Removal — all drugs for Chest Tube Removal →
- Children — all drugs for Children →
- Pain Management — all drugs for Pain Management →
Sponsor
Istanbul Medeniyet University
Who can join
Adults 8 to 18, any sex, with Chest Tube Removal or Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is being conducted to determine the effect of EMLA cream and cold application on pain, fear and vital signs before chest tube removal in children aged 7-18 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06913855
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of EMLA Cream
Trials testing the same drug.
- NCT06023368 — Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray · Phase 4 · withdrawn
- NCT05970354 — EMLA Cream as Analgesic for Outpatient Gynecological Procedures · Phase 4 · enrolling by invitation
- NCT05060913 — Emla Cream Versus Benzocaine on Analgesia · EARLY_PHASE1 · completed
- NCT04337814 — The Effect of Combined Oral and Topical Analgesics to Reduce Pain Perception During Electrodiagnostic Testing · NA · completed
- NCT04026074 — Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations. · Phase 4 · completed
Other recruiting trials for Chest Tube Removal
Currently open trials in the same condition.
- NCT07528482 — Effects of Reflexology and Cold Application Before Chest Tube Removal in CABG Patients · NA · recruiting
- NCT06444854 — Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study · NA · recruiting
Other Istanbul Medeniyet University trials
Trials by the same sponsor.
- NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
- NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
- NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
- NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
- NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06913855 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
- Last refreshed: 14 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06913855.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing